Oct 2
|
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
|
Sep 30
|
Genenta Science S.p.A. (GNTA): Early Investment Opportunity in Innovative Biotech
|
Apr 26
|
Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
|